Ceire Costelloe BA(hons) MSc PhD CStat trained in Medical Statistics after studying Immunology at Trinity College Dublin.
She is a Senior Lecturer in the Department of Primary Care and Public health and Director of the Global digital health unit at Imperial.
She leads a team of doctoral and postdoctoral researchers funded through the NIHR, ESRC and the Wellcome trust, addressing key questions in infection related and antimicrobial resistant infection (AMR). She holds a personal NIHR Career Development Fellowship which funds research evaluating interventions targeting AMR using routinely collected clinical data and novel statistical causal inference methods.
From 2015-2018 she was a Lecturer within the NIHR HPRU in HCAI and AMR at Imperial, and she maintains close collaboration with the unit. She has experience working in clinical trials both with the Bristol Randomised trials unit and the NIHR pragmatic clinical trials unit at Queen Mary University London.
More details about the Global Digital health unit, including opportunities, can be found here: Global Digital Health unit
et al., Evaluating a digital sepsis alert in a London multi-site hospital network: a natural experiment using electronic health record data, Journal of the American Medical Informatics Association, ISSN:1067-5027
et al., 2019, Health Professions Digital Education on Antibiotic Management: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration, Journal of Medical Internet Research, Vol:21, ISSN:1438-8871
Anyanwu P, Costelloe C, Investigating the mechanism of impact of the quality premium initiative on antibiotic prescribing in primary care practices in England: A study protocol., Bmj Open, ISSN:2044-6055
et al., Preschool respiratory hospital admissions following infant bronchiolitis: a birth cohort study, Archives of Disease in Childhood, ISSN:1468-2044
et al., 2018, Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis, Journal of Antimicrobial Chemotherapy, Vol:73, ISSN:0305-7453, Pages:2883-2892